Nora Volkow, the director of the National Institute on Drug Abuse (NIDA), recently spoke out in defense of the agency amidst a wave of policy changes at the National Institutes of Health (NIH). In a candid interview at the NIH campus in Bethesda, Maryland, Volkow expressed her concerns about the impact of these changes on her work.
When asked about the effect of the recent policy changes on her daily routine, Volkow humorously admitted that they had “increased [her] blood pressure and heart rate.” However, she declined to delve into specifics about the Trump administration’s policies, redirecting inquiries to the Department of Health and Human Services.
As the head of NIDA since 2003, Volkow has been at the forefront of addiction research, overseeing a substantial budget of approximately $1.6 billion. Despite the challenges posed by external factors, Volkow remains dedicated to advancing the agency’s mission to combat drug addiction and improve public health.
Unfortunately, the rest of the article is restricted to STAT+ subscribers, limiting access to in-depth analysis and news alerts. To unlock the full story and gain access to premium content, readers are encouraged to subscribe to STAT+. By subscribing, individuals can stay informed about the latest developments in drug addiction research and policy changes at the NIH.
In conclusion, Volkow’s unwavering commitment to NIDA’s work underscores the importance of ongoing research and funding in the field of addiction. As the landscape of healthcare policy continues to evolve, it is crucial to support organizations like NIDA in their efforts to address the complex challenges of substance abuse and addiction.
